Both Drs. Cass and Cheung felt that the reimbursement issue may not create as much pressure to offer the intratympanic injection as Dr. Rauch feared. Reimbursement is an issue I hadn’t considered, Dr. Cheung said. My sense is that, overall, given the uncommon nature of the problem, the generation of revenue is an unlikely motive for choosing intratympanic steroids. It can’t possibly constitute enough of a revenue stream.
Explore This IssueApril 2006
I think the strongest influence toward offering intratympanic injections is wanting the best for the patients and also wanting to be on the cutting edge, said Dr. Cass.
©2006 The Triological Society